Click Here For COVID-19 (Coronavirus) Studies

Trials Offered by a Specific Doctor

Christine Kim Garcia, MD
Dr. Christine Kim Garcia, MD, PhD is board certified in Pulmonary Disease and Critical Care Medicine. In October 2018, she joined Columbia University Irving Medical Center as the Frode Jensen Professor of Medicine, the Associate Director of the Division of Pulmonary, Allergy and Critical Care Medicine, and Co-Director of the Interstitial Lung Disease Program. She has appointments in the Department of Medicine, the Institute for Genomic Medicine, and the Center for Human Genetics and Genomic Medicine. Her clinic specializes in the care of patients with inherited interstitial lung disease.

Dr. Garcia has a long-standing interest in the genetics of adult-onset lung disease. Her laboratory has discovered rare mutations in several genes (TERT, TERC, SFTPA2, PARN, RTEL1, FLCN) that are linked to inherited forms of interstitial lung disease. These discoveries have implicated the surfactant and telomere pathways to the pathogenesis of lung fibrosis. She and her colleagues have shown that telomere lengths of circulating blood cells predict clinical outcomes of Idiopathic Pulmonary Fibrosis (IPF) patients, including survival, rate of progression, and response to medications. She is the principal investigator of a number of studies at Columbia University.

Clinical Studies Managed By Dr. Garcia:
More InfoTitleSponsorIRB Number
DetailsFAR-ILD: The Families At Risk for Interstitial Lung Disease StudyNIHAAAR1916
DetailsMolecular Basis of Cardiopulmonary DisordersNIHAAAS0753
DetailsPrecision Medicine Approach to Lung DiseaseColumbia UniversityAAAS4094
DetailsPrecision Medicine Approach to Lung Disease (Healthy Participants)Columbia UniversityAAAS4094
DetailsThe Molecular Basis of Cardiopulmonary Disorders (Healthy participants and children over 7 welcome)NIHAAAS0753
DetailsFolks-At-Risk for Interstitial Lung Disease due to COVID-19National Institutes of HealthAAAR1916C
DetailsFolks-At-risk for Interstitial Lung Disease due to Smoking HistoryNational Institute of HealthAAAR1916S
DetailsFolks-At-Risk for Interstitial Lung Disease (FAR-ILD) (Healthy Volunteers)National Institute of HealthAAAR1916